We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Unveils Plans to Regulate LDTs; Launch Set for 6 Months after Final Guidance
FDA Unveils Plans to Regulate LDTs; Launch Set for 6 Months after Final Guidance
For the first time, the FDA will begin regulating manufacturers of high to moderate risk laboratory-developed tests, a move that reverses the long-standing agency position that LDTs were not subject to FDA oversight.